BurnZero
Certificate in Psychedelic Assisted Therapy: Difference between revisions

Certificate in Psychedelic Assisted Therapy: Difference between revisions

From BurnZero
No edit summary
mNo edit summary
 
(17 intermediate revisions by the same user not shown)
Line 1: Line 1:
The provision of a supportive therapeutic setting prior to, during, and following drug administration is now the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. To fill this requirement, a variety of psychedelic-assisted therapy (PAT) models and certifications (CPAT) have been developed to ensure the [[Guided Psychedelic Therapy|guiding clinician]] is sufficiently competent. Many courses worldwide have been created using guidelines specifically developed in the US<ref>Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017).  Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304</ref>. These include:
<seo title="Psychedelic Assisted Therapy Certificate" metakeywords="CPAT, psychedelic assisted therapy australia, psychedelic assisted therapy melbourne " metadescription="What is the best psychedelic-assisted therapy courses?"/>
<div class="res-img">[[File:OSPAT certificate.png|alt=Certificate in Psychedelic Assisted Therapy|center|Psychedelic medicine lecture]]
</div>'''A Certificate in Psychedelic Assisted Therapy (CPAT), is the result of the successful completion of a Psychedelic Assisted Therapy Course (PATC). PATCs are courses developed by various organisations (see below) in order to teach [[Guided Psychedelic Therapy|guiding clinicians]] best practice techniques when guiding patients prior, during, and following a psychedelic experience.'''


* '''Embark'''<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref> - Canadian / US proprietary training created by Cybin ltd first released in June 2022.
Numerous studies<ref>'''Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.''' Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041963/ 10.3389/fphar.2018.00733]. </ref><ref>'''Ethical and legal issues in psychedelic harm reduction and integration therapy'''. Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea & Vilmarie Fraguada Narloch. Harm Reduction Journal volume 18, Article number: 40 (2021)</ref> and a systematic review<ref>'''A systematic review of psychedelic-assisted psychotherapy for mental health''': An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020).  Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. <nowiki>https://doi.org/10.1037/cns0000237</nowiki></ref> have concluded that supportive therapeutic guidance should be considered the standard of care in the majority of uses of [[Psychedelics|psychedelic medications]] for the treatment of psychiatric disorders. As there is currently a world wide shortage of psychedelic integration guides<ref>'''MDMA-Therapy Expert Dr. Rick Doblin''': Boston Magazine. Initially published in 2019 accessed on 9th August 2022 via <nowiki>https://www.bostonmagazine.com/health/2019/09/10/rick-doblin/</nowiki></ref>, a wide array of courses have been developed to encourage more people to become guides. Psychedelic Assisted Therapy training guidelines were initially developed in the US<ref>Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017).  Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304</ref> however, more recently there has been the establishment of an increasing number of courses worldwide, these include: 
*'''CPAT''' - Australian proprietary training created by Mind Medicine Australia.  


By comparing and contrasting each offering a new [[Open Source Psychedelic-Assisted Therapy]] has been developed. Below is a brief summary of the analysis.
* '''[https://cybin.com/embark/ Embark]''' - Canadian / US proprietary training created by Cybin ltd first released in June 2022<ref>'''Models of Psychedelic-Assisted Psychotherapy''': A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>.
*'''[https://cpat.mindmedicineaustralia.org/ CPAT]''' - Australian proprietary training created by Mind Medicine Australia.
*'''[https://www.ciis.edu/research-centers/center-for-psychedelic-therapies-and-research/about-the-certificate-in-psychedelic-assisted-therapies-and-research#:~:text=CIIS%20has%20an%20outstanding%20reputation,esteemed%20team%20led%20by%20Dr. CIIS]''' - California Institute of Integral Studies, certifies for Psychedelic Therapies and Research.
*'''[https://www.fluencetraining.com/training/ Fluence]''' - a private psychological services company fully owned and operated by Dr. Ingmar Gorman and Dr. Elizabeth Nielson'''.'''
*'''[https://mapspublicbenefit.com/training/ MAPS]''' -  [[MDMA]] Training Therapy Program
*'''[https://www.scptr.org/psychedelic-therapy-training-program- SCPTR]''' - ''Salt City Psychedelic Therapy & Research'' is to educate and train. This 8-week live virtual program.
 
In late 2022, a multidisciplinary healthcare team convened consisting of psychotherapists, psychiatrists, neuropsychopharmacologists and mental health nurses to review the content of the courses listed above. It was found whilst the content was satisfactory (see summary of analysis below) that the financial incentives behind the creation of such a course biased the content of the course itself. For example, many of the courses offered above were been created on the basis that the practitioner works within a structured clinical pathway which would require the use of proprietary medicines. As a result, to remove this potential for bias the multidisciplinary group created the world's first [[Open Source Psychedelic-Assisted Therapy]] (OSPAT) which is available for anyone to use, free of charge.


== CPAT Content ==
== CPAT Content ==
[[File:Certificate in Psychedelic Assisted Therapy.png|alt=Certificate in Psychedelic Assisted Therapy|thumb|'''Figure 1'''. Open Sourced Certificate in Psychedelic Assisted Therapy]]
The majority of PAP models have drawn influence from 3 main sources<ref>Phelps, J. (2017). ''Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology, 57(5), 450–487.'' doi:10.1177/0022167817711304</ref>:
The majority of PAP models have drawn influence from 3 main sources<ref>Phelps, J. (2017). ''Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology, 57(5), 450–487.'' doi:10.1177/0022167817711304</ref>:


Line 19: Line 28:


== CPAT Structure ==
== CPAT Structure ==
All PAT training models training the practitioner to concentrate on three key phases of therapy<ref>'''The Psychotherapeutic Framing of Psychedelic Drug Administration'''. Front. Psychol.,  Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. Preparation sessions make up the first stage and are intended to get individuals ready to benefit from the medication. The second stage of therapy is referred to as the medicine session(s), which refers to the period when medication is administered. The third phase, often known as "''integration''"<ref>'''Psychedelic harm reduction and integration: a transtheoretical model for clinical practice.''' Gorman, I., Nielson, E. M., Molinar, A., Cassidy, K., and Sabbagh, J. (2021).  ''Front. Psychol.'' 12:645246. doi: 10.3389/fpsyg.2021.645246</ref> involves a process of reflection on the medicine session and how it could motivate cognitive and behavioural changes that last after the course of therapy.
All PAT training models train the practitioner to concentrate on three key phases of [[Psychedelic Therapy|psychedelic therapy]]<ref>'''The Psychotherapeutic Framing of Psychedelic Drug Administration'''. Front. Psychol.,  Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: <nowiki>https://doi.org/10.3389/fpsyg.2022.866018</nowiki></ref>. These include:
 
# '''Preparation''' session(s) make up the first stage and are intended to [[Priming|prime]] individuals to get ready to benefit from the medication.  
# '''Medicine''' session(s), which refers to the period when medication is administered.  
# '''Integration''' involves a process of reflection on the medicine session and how it could motivate cognitive and behavioural changes that last after the course of therapy.
 
How to manage these three phases is taught via a syllabus which covers:
 
* '''History of Psychedelics''': Philosophy, Indigenous Traditions, Renaissance.
* '''Types of therapy''': Legality, Ethics.
* '''Medical attributes of Psychedelics''': Current Research, Addiction, Depression, PTSD & Trauma.
* '''Navigating the experience''':  Preparation, Spaceholding, Set and Setting: [[Music and Psychedelic Experiences|Music]] Theory.
* '''Integration''': Harm Reduction.


== Clinical Governance ==
== Clinical Governance ==
Due to the inducement of a neuroplastic state the vulnerability of the patient increases. Conduct of practice should be guided by a specific code of ethics and followed by a transparent clinical governance mechanism.
Due to the inducement of a [[Neuroplasticity|neuroplastic]] state the vulnerability of the patient increases. Conduct of practice should be guided by a specific code of ethics and followed by a transparent clinical governance mechanism.
<hr>
<hr>
'''References'''
'''References'''
<references />
<references />

Latest revision as of 23:10, 2 May 2024

Certificate in Psychedelic Assisted Therapy

A Certificate in Psychedelic Assisted Therapy (CPAT), is the result of the successful completion of a Psychedelic Assisted Therapy Course (PATC). PATCs are courses developed by various organisations (see below) in order to teach guiding clinicians best practice techniques when guiding patients prior, during, and following a psychedelic experience.

Numerous studies[1][2] and a systematic review[3] have concluded that supportive therapeutic guidance should be considered the standard of care in the majority of uses of psychedelic medications for the treatment of psychiatric disorders. As there is currently a world wide shortage of psychedelic integration guides[4], a wide array of courses have been developed to encourage more people to become guides. Psychedelic Assisted Therapy training guidelines were initially developed in the US[5] however, more recently there has been the establishment of an increasing number of courses worldwide, these include:

  • Embark - Canadian / US proprietary training created by Cybin ltd first released in June 2022[6].
  • CPAT - Australian proprietary training created by Mind Medicine Australia.
  • CIIS - California Institute of Integral Studies, certifies for Psychedelic Therapies and Research.
  • Fluence - a private psychological services company fully owned and operated by Dr. Ingmar Gorman and Dr. Elizabeth Nielson.
  • MAPS - MDMA Training Therapy Program
  • SCPTR - Salt City Psychedelic Therapy & Research is to educate and train. This 8-week live virtual program.

In late 2022, a multidisciplinary healthcare team convened consisting of psychotherapists, psychiatrists, neuropsychopharmacologists and mental health nurses to review the content of the courses listed above. It was found whilst the content was satisfactory (see summary of analysis below) that the financial incentives behind the creation of such a course biased the content of the course itself. For example, many of the courses offered above were been created on the basis that the practitioner works within a structured clinical pathway which would require the use of proprietary medicines. As a result, to remove this potential for bias the multidisciplinary group created the world's first Open Source Psychedelic-Assisted Therapy (OSPAT) which is available for anyone to use, free of charge.

CPAT Content

Certificate in Psychedelic Assisted Therapy
Figure 1. Open Sourced Certificate in Psychedelic Assisted Therapy

The majority of PAP models have drawn influence from 3 main sources[7]:

  • Early work of PAP pioneers - mainly Grof, Greer and Tolbert and Stolaroff.
  • Indigenous approaches[8]
  • Non-psychedelic therapeutic approaches[9]

However, one often neglected source of data is accumulated by people who use psychedelics (PWUP) outside of clinical contexts[10]. All sources highlight the need for controlling three key parameters:

  1. Patient attributes: medical exclusions, psychological framing.
  2. Setting attributes: music, light, furnishing, nature immersion[11].
  3. Clinician attributes: background, experience, theoretical certification (such as CPAT)

CPAT Structure

All PAT training models train the practitioner to concentrate on three key phases of psychedelic therapy[12]. These include:

  1. Preparation session(s) make up the first stage and are intended to prime individuals to get ready to benefit from the medication.
  2. Medicine session(s), which refers to the period when medication is administered.
  3. Integration involves a process of reflection on the medicine session and how it could motivate cognitive and behavioural changes that last after the course of therapy.

How to manage these three phases is taught via a syllabus which covers:

  • History of Psychedelics: Philosophy, Indigenous Traditions, Renaissance.
  • Types of therapy: Legality, Ethics.
  • Medical attributes of Psychedelics: Current Research, Addiction, Depression, PTSD & Trauma.
  • Navigating the experience: Preparation, Spaceholding, Set and Setting: Music Theory.
  • Integration: Harm Reduction.

Clinical Governance

Due to the inducement of a neuroplastic state the vulnerability of the patient increases. Conduct of practice should be guided by a specific code of ethics and followed by a transparent clinical governance mechanism.

References

  1. ↑ Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development. Eduardo Ekman Schenberg. Front Pharmacol. 2018; 9: 733. Published online 2018 Jul 5. doi: 10.3389/fphar.2018.00733.
  2. ↑ Ethical and legal issues in psychedelic harm reduction and integration therapy. Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea & Vilmarie Fraguada Narloch. Harm Reduction Journal volume 18, Article number: 40 (2021)
  3. ↑ A systematic review of psychedelic-assisted psychotherapy for mental health: An evaluation of the current wave of research and suggestions for the future. Wheeler, S. W., & Dyer, N. L. (2020).  Psychology of Consciousness: Theory, Research, and Practice, 7(3), 279–315. https://doi.org/10.1037/cns0000237
  4. ↑ MDMA-Therapy Expert Dr. Rick Doblin: Boston Magazine. Initially published in 2019 accessed on 9th August 2022 via https://www.bostonmagazine.com/health/2019/09/10/rick-doblin/
  5. ↑ Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Phelps, J. (2017). Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304
  6. ↑ Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. William Brennan and Alexander B. Belser. Cybin, Inc., Toronto, ON, Canada and Fordham University, New York City, NY, United States. Front. Psychol., 02 June 2022 https://doi.org/10.3389/fpsyg.2022.866018
  7. ↑ Phelps, J. (2017). Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology, 57(5), 450–487. doi:10.1177/0022167817711304
  8. ↑ The role of Indigenous knowledges in psychedelic science. Fotiou, E. (2020). J. Psychedelic Stud. 4, 16–23. doi: 10.1556/2054.2019.031
  9. ↑ Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy. Walsh, Z., and Thiessen, M. S. (2018). Int. Rev. Psychiatry 30, 343–349. doi: 10.1080/09540261.2018.1474088
  10. ↑ Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers. Thal S, Engel LB, Bright SJ. Journal of Humanistic Psychology. March 2022. doi:10.1177/00221678221081380
  11. ↑ Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy Agnieszka D. Sekula1,2*, Luke Downey1,3 and Prashanth Puspanathan2 1 Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, VIC, Australia, 2 Enosis Therapeutics Pty. Ltd., Melbourne, VIC, Australia, 3 Institute for Breathing and Sleep, Austin Hospital, Melbourne, VIC, Australia
  12. ↑ The Psychotherapeutic Framing of Psychedelic Drug Administration. Front. Psychol., Sec. Psychology for Clinical Settings. Published: 02 June 2022, accessed on 9th August 2022 via: https://doi.org/10.3389/fpsyg.2022.866018
Retrieved from "https://burnzero.com/index.php?title=Certificate_in_Psychedelic_Assisted_Therapy&oldid=5732"

Share your opinion